Financhill
Back

Century Therapeutics Stock Predictions

Century Therapeutics Stock Forecast

  • Is Century Therapeutics Stock Undervalued?
    The current Century Therapeutics [IPSC] share price is $0.57. The Score for IPSC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • IPSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Century Therapeutics Stock Go Up Next Year?

Data Unavailable

Century Therapeutics Stock Rating

Data Unavailable

Century Therapeutics Stock Price History

Is IPSC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPSC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
centurytx.com

52-Week Data

52-Week High:
3.29
52-Week Low:
0.34

Prediction Charts

Market Cap:
48.9M
Price in USD:
0.57
Volume:
446.8K
Beta:
1.80

Technical Analysis

SMA50:
0.56
SMA100:
0.59
SMA200:
0.96
52-Wk Change:
-76.93%

Stock Predictions

  • Is Century Therapeutics stock public?
    Yes, Century Therapeutics is a publicly traded company.
  • What is the Century Therapeutics stock quote today?
    The Century Therapeutics stock price is 0.57 USD today.
  • How to buy Century Therapeutics stock online?
    You can buy Century Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-6 0.57 0.62 0.65 0.56
Jun-9 0.62 0.63 0.64 0.61
Jun-10 0.65 0.63 0.66 0.62
Jun-11 0.65 0.61 0.65 0.57
Jun-12 0.62 0.60 0.62 0.59
Jun-13 0.60 0.58 0.61 0.56
Jun-16 0.59 0.58 0.61 0.58
Jun-17 0.58 0.59 0.61 0.58
Jun-18 0.58 0.59 0.60 0.58
Jun-20 0.59 0.58 0.60 0.57
Jun-23 0.58 0.58 0.59 0.55
Jun-24 0.58 0.59 0.60 0.57
Jun-25 0.60 0.57 0.60 0.56
Jun-26 0.57 0.57 0.59 0.55

Century Therapeutics Earnings

Data Unavailable

Century Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.32 per share, and a decrease next year of $1.37 per share.

* Century Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.